BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34794461)

  • 1. Extranodal natural killer/T-cell lymphoma of the breast: a retrospective clinicopathological analysis of a consecutive 11-year case series.
    Liu W; Chen Z; Li F; Zhang W; Liu W; Zhao S
    Orphanet J Rare Dis; 2021 Nov; 16(1):479. PubMed ID: 34794461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extranodal natural killer/T-cell lymphoma with hepatosplenic involvement: a retrospective study of a consecutive 14-year case series.
    Zhang YH; Li Z; Zhao S; Zhang WY; Liu QL; Liu WP; Gao LM
    Ann Hematol; 2023 Oct; 102(10):2803-2813. PubMed ID: 37434096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological study of pulmonary extranodal nature killer/T-cell lymphoma, nasal type and literature review.
    Ding W; Wang J; Zhao S; Yang Q; Sun H; Yan J; Gao L; Yao W; Zhang W; Liu W
    Pathol Res Pract; 2015 Jul; 211(7):544-9. PubMed ID: 25953340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant effusions from extranodal NK/T-cell lymphomas are frequently of anaplastic morphology with azurophilic granules and of T-cell lineage.
    Liu CY; Chen BJ; Chuang SS;
    Diagn Cytopathol; 2020 May; 48(5):453-463. PubMed ID: 32020785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD30 expression in extranodal natural killer/T-cell lymphoma, nasal type among 622 cases of mature T-cell and natural killer-cell lymphoma at a single institution in South China.
    Feng Y; Rao H; Lei Y; Huang Y; Wang F; Zhang Y; Xi S; Wu Q; Shao J
    Chin J Cancer; 2017 May; 36(1):43. PubMed ID: 28486951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extranodal natural-killer/T-cell lymphoma, nasal type: An immunomorphological study from a regional cancer institute in India.
    Agrawal M; Champaka G; Amirtham U; Jacob LA; Premalata CS
    J Cancer Res Ther; 2022; 18(4):1137-1143. PubMed ID: 36149173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extranodal NK/T-cell lymphoma in Tunisia: clinicopathological features, immunophenotype and EBV infection.
    Missaoui N; Mestiri S; Bouriga A; Abdessayed N; Belakhdher M; Ghammem M; Abdelkefi M; Mokni M; Hmissa S
    J Egypt Natl Canc Inst; 2019 Oct; 31(1):1. PubMed ID: 32372136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute Epstein-Barr virus-positive cytotoxic T cell lymphoid hyperplasia in the upper aerodigestive tract, mimicking extranodal natural killer/T cell lymphoma, nasal type.
    Jianlan X; Yuhua H; Yuanyuan Z; Yanlin Z; Ping W; Wei L; Xiaoge Z; Mulan J
    Virchows Arch; 2019 Feb; 474(2):219-226. PubMed ID: 30488123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders.
    Takahashi E; Ohshima K; Kimura H; Hara K; Suzuki R; Kawa K; Eimoto T; Nakamura S;
    Histopathology; 2011 Oct; 59(4):660-71. PubMed ID: 22014047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous extranodal natural killer/T-cell lymphoma: a comparative clinicohistopathologic and survival outcome analysis of 45 cases according to the primary tumor site.
    Lee WJ; Jung JM; Won CH; Chang SE; Choi JH; Chan Moon K; Park CS; Huh J; Lee MW
    J Am Acad Dermatol; 2014 Jun; 70(6):1002-9. PubMed ID: 24629518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus-negative extranodal "true" natural killer-cell lymphoma harbouring a KDM6A mutation.
    Tsuyama N; Asaka R; Dobashi A; Baba S; Mishima Y; Ueda K; Oguchi M; Tsuji H; Hatake K; Takeuchi K
    Hematol Oncol; 2018 Feb; 36(1):328-335. PubMed ID: 28695659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extranodal natural killer/T-cell lymphoma, nasal type: a Spanish multicentric retrospective survey.
    Rozas-Muñoz E; Gallardo F; Pujol RM; Pérez-Ferriols A; Servitje O; Estrach T; Bastida J; Román C; Palacio-Aller L; Gil I; Martí RM; Vidal-Sarró D; García-Muret MP
    Eur J Dermatol; 2018 Feb; 28(1):64-70. PubMed ID: 29400283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative population-based analysis of sinonasal diffuse large B-cell and extranodal NK/T-cell lymphomas.
    Dubal PM; Dutta R; Vazquez A; Patel TD; Baredes S; Eloy JA
    Laryngoscope; 2015 May; 125(5):1077-83. PubMed ID: 25546466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases.
    Haverkos BM; Pan Z; Gru AA; Freud AG; Rabinovitch R; Xu-Welliver M; Otto B; Barrionuevo C; Baiocchi RA; Rochford R; Porcu P
    Curr Hematol Malig Rep; 2016 Dec; 11(6):514-527. PubMed ID: 27778143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extranodal natural killer/T-Cell lymphoma: A population-based comparison of sinonasal and extranasal disease.
    Vazquez A; Khan MN; Blake DM; Sanghvi S; Baredes S; Eloy JA
    Laryngoscope; 2014 Apr; 124(4):888-95. PubMed ID: 24114591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression and clinical significance of programmed cell death receptor 1 and its ligand in tumor tissues of patients with extranodal nasal NK/T cell lymphoma.
    Feng Y; Feng X; Jing C; Yu X; Zheng Y; Xu C
    Sci Rep; 2022 Jan; 12(1):36. PubMed ID: 34996890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysis.
    Kim SJ; Choi JY; Hyun SH; Ki CS; Oh D; Ahn YC; Ko YH; Choi S; Jung SH; Khong PL; Tang T; Yan X; Lim ST; Kwong YL; Kim WS;
    Lancet Haematol; 2015 Feb; 2(2):e66-74. PubMed ID: 26687611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting treatment response of patients with extranodal natural killer/T-cell lymphoma based on levels of PD-L1 mRNA and soluble PD-L1.
    Feng Y; Jing C; Yu X; Cao X; Xu C
    Hematol Oncol; 2020 Oct; 38(4):467-477. PubMed ID: 32515093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extranodal nasal-type natural killer/T-cell lymphoma with penile involvement: a case report and review of the literature.
    Wang X; Gong Z; Li SX; Yan W; Song Y
    BMC Urol; 2017 Sep; 17(1):77. PubMed ID: 28874193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD56-negative extranodal NK/T cell lymphoma should be regarded as a distinct subtype with poor prognosis.
    Wang L; Wang Z; Xia ZJ; Lu Y; Huang HQ; Zhang YJ
    Tumour Biol; 2015 Sep; 36(10):7717-23. PubMed ID: 25935537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.